This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Sanwa Kagaku Kenkyusho Co., Ltd., Nippon Paper Industries Co., Ltd.. Active years: 1995-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Aichi, JP (1995)
- Nagoya, JP (1995 - 2011)
Company Filing History:

Years Active: 1995-2011
Title: Innovations of Yuji Hayashi in Plant Biotechnology
Introduction
Yuji Hayashi is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of plant biotechnology, particularly in the development of transgenic plants that can aid in diabetes treatment. With a total of six patents to his name, his work focuses on the accumulation of GLP-1 derivatives in plants.
Latest Patents
Hayashi's latest patents include innovative methods for producing plants and plant storage organs that accumulate GLP-1 derivatives. One of his key inventions involves transgenic plants that produce tandem repeated GLP-1 derivatives, which are cleavable by intestinal digestive enzymes into monomeric molecules. This method includes integrating specific DNAs into vectors, introducing them into plant cells, and redifferentiating the resulting transformants. These edible transgenic plants are particularly beneficial for diabetic patients, as they can be ingested to help manage their condition. Another significant patent focuses on producing a recombinant protein in plant storage organs, utilizing a vector that comprises a recombinant protein gene, a cytokinin-related gene, and a drug-resistant gene.
Career Highlights
Throughout his career, Yuji Hayashi has worked with prominent companies such as Sanwa Kagaku Kenkyusho Co., Ltd. and Nippon Paper Industries Co., Ltd. His experience in these organizations has contributed to his expertise in plant biotechnology and innovation.
Collaborations
Hayashi has collaborated with notable coworkers, including Takahito Jomori and Mitsuhiro Makino. Their joint efforts have further advanced the research and development of transgenic plants.
Conclusion
Yuji Hayashi's contributions to plant biotechnology, particularly in the area of GLP-1 derivatives, showcase his innovative spirit and dedication to improving health outcomes for diabetic patients. His work continues to influence the field and offers promising solutions for future applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile